Sign in
4

Changes in Ownership

Lineage Cell Therapeutics, Inc. Filed Acc 0001209191-16-113920

Options or other derivatives

  • Co-Chief Executive Officer acquired 200,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

WEST MICHAEL D · Co-Chief Executive Officer

Table II: Derivative

2 lines
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2016-04-07 Grant or award : show line 1 in the form Option to Purchase Common Shares +175,000 $3.16 2026-04-06 175,000 175,000 D
2016-04-07 Grant or award : show line 2 in the form Restricted Stock Units +25,000 25,000 25,000 D
Loading xslF345X03/doc4.xml…